Menu

March Methods Madness

Thomson Reuters launches Metrics Mania, which will pit universities against each other, not on the basketball court, but in the scientific literature.

Mar 20, 2013
Bob Grant

Penn State vs. Colgate, circa 2007WIKIMEDIA, BEN STANFIELDAs the hoops action heats up in the world of college basketball, information company Thomson Reuters is rolling out its citation-based answer to March Madness. “Metrics Mania” will compare the institutional research productivity between the 64 colleges and universities from across the country that will square off starting tomorrow (March 21) in NCAA men’s basketball. Champions of both the basketball tournament and the research contest will be crowned on April 8. Using citation data derived from their Web of Knowledge, Thomson Reuters will provide regular updates concerning head-to-head matchups of the schools competing against each other on the court.

“We are very excited to host the first-ever Metrics Mania,” said Gordon Macomber, managing director of Scientific and Scholarly Research at Thomson Reuters, in a statement. “Not only will this be a fun program for the scholarly research community, but it will also give Thomson Reuters an opportunity to highlight the great research programs within the schools competing in our brackets.”

Bracket heads can follow along with the action at the Metrics Mania website, as well as on Twitter and Facebook.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.